135 related articles for article (PubMed ID: 37247662)
21. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
22. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients.
Shah SU; Mashayekhi A; Shields CL; Walia HS; Hubbard GB; Zhang J; Shields JA
Ophthalmology; 2014 Jan; 121(1):352-357. PubMed ID: 23988200
[TBL] [Abstract][Full Text] [Related]
23. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
[TBL] [Abstract][Full Text] [Related]
24. [Glaucoma treatment].
Bluwol E
Rev Prat; 2016 May; 66(5):508-513. PubMed ID: 30512573
[TBL] [Abstract][Full Text] [Related]
25. Cyclodestructive procedures for non-refractory glaucoma.
Michelessi M; Bicket AK; Lindsley K
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009313. PubMed ID: 29694684
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma.
Vale S; Montalvo L; Baez E; Oliver AL
Am J Ophthalmol Case Rep; 2018 Mar; 9():45-47. PubMed ID: 29468218
[TBL] [Abstract][Full Text] [Related]
27. [Neovascular glaucoma--etipathogeny and diagnosis].
Călugăru D; Călugăru M
Oftalmologia; 2012; 56(2):3-14. PubMed ID: 23424756
[TBL] [Abstract][Full Text] [Related]
28. Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture.
Shields CL; Kaliki S; Crabtree GS; Peshtani A; Morton S; Anand RA; Coco G; Shields JA
Cornea; 2015 Jan; 34(1):42-8. PubMed ID: 25343701
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of micropulse transscleral diode cyclophotocoagulation in refractory glaucoma: 1 year results.
Jammal AA; Costa DC; Vasconcellos JPC; Costa VP
Arq Bras Oftalmol; 2019 Jun; 82(5):381-388. PubMed ID: 31271570
[TBL] [Abstract][Full Text] [Related]
30. Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign.
Vempuluru VS; Jakati S; Krishnamurthy R; Senthil S; Kaliki S
Int Ophthalmol; 2020 Jul; 40(7):1789-1795. PubMed ID: 32198607
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma metastatic to the eye and orbit II. A clinicopathological study of 26 patients with carcinoma metastatic to the anterior segment of the eye.
Ferry AP; Font RL
Arch Ophthalmol; 1975 Jul; 93(7):472-82. PubMed ID: 166633
[TBL] [Abstract][Full Text] [Related]
32. Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma.
Hennis HL; Stewart WC
Am J Ophthalmol; 1992 Jan; 113(1):81-5. PubMed ID: 1728152
[TBL] [Abstract][Full Text] [Related]
33. Transscleral cyclophotocoagulation with MicroPulse
Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Papadonta SA; Armeni EZ; Kohlhaas M
Int Ophthalmol; 2021 Apr; 41(4):1271-1282. PubMed ID: 33392944
[TBL] [Abstract][Full Text] [Related]
34. Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma.
Pokroy R; Greenwald Y; Pollack A; Bukelman A; Zalish M
Ophthalmic Surg Lasers Imaging; 2008; 39(1):22-9. PubMed ID: 18254347
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
36. [Secondary glaucoma due to progressive iris atrophy--a century after the first description. Case report].
Jurowski P; Goś R; Kapica A; Zdzieszyńska M
Klin Oczna; 2004; 106(1-2):80-2. PubMed ID: 15218772
[TBL] [Abstract][Full Text] [Related]
37. [Secondary glaucoma caused by iris tumor. Iris metastasis of adenocarcinoma of the breast].
Höche A; Blum M; Semeniuk C; Lorenz P; Kosmehl H; Strobel J
Ophthalmologe; 1999 May; 96(5):342-3. PubMed ID: 10414125
[No Abstract] [Full Text] [Related]
38. Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.
Nakashima C; Keino H; Watanabe T; Taki W; Okada AA
Jpn J Ophthalmol; 2011 Jan; 55(1):80-1. PubMed ID: 21331703
[No Abstract] [Full Text] [Related]
39. [Intraocular pressure results of contact transscleral cyclophotocoagulation with Neodymium YAG laser for refractory glaucoma].
Quintyn JC; Grenard N; Hellot MF; Gruber D; Brasseur G
J Fr Ophtalmol; 2003 Oct; 26(8):808-12. PubMed ID: 14586221
[TBL] [Abstract][Full Text] [Related]
40. Uveitis-Glaucoma-Hyphaema Syndrome. General review.
Zemba M; Camburu G
Rom J Ophthalmol; 2017; 61(1):11-17. PubMed ID: 29450365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
